These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27569202)

  • 1. Safety profiling of pioglitazone and telmisartan combination by sub-chronic toxicity study in rat.
    Sengupta P; Das A; Ibrahim F; Mandal UK; Chatterjee B; Mahmood S; Das SK; Kifayatullah M
    Regul Toxicol Pharmacol; 2016 Nov; 81():155-161. PubMed ID: 27569202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, pharmacodynamics and toxicity of a combination of metoprolol succinate and telmisartan in Wistar albino rats: safety profiling.
    Nandi U; Karmakar S; Das AK; Ghosh B; Padman A; Chatterjee N; Pal TK
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):68-78. PubMed ID: 23201407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination.
    Sengupta P; Chatterjee B; Pal TK
    Regul Toxicol Pharmacol; 2017 Dec; 91():151-158. PubMed ID: 29107617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of safety profile evaluating pharmacokinetics, pharmacodynamics and toxicity of a combination of pioglitazone and olmesartan medoxomil in Wistar albino rats.
    Sengupta P; Nandi U; Pal TK
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):7-15. PubMed ID: 22203042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats.
    Shahataa MG; Mostafa-Hedeab G; Ali EF; Mahdi EA; Mahmoud FA
    Can J Physiol Pharmacol; 2016 Aug; 94(8):907-17. PubMed ID: 27245695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion.
    Gorain B; Choudhury H; Tekade RK; Karan S; Jaisankar P; Pal TK
    Regul Toxicol Pharmacol; 2016 Dec; 82():20-31. PubMed ID: 27815174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug synergism of antihypertensive action in combination of telmisartan with lercanidipine in spontaneous hypertensive rats.
    Lee JJ; Shin CY; Park HJ; Zhang WY; Kim Y; Kim IS; Lee KH; Myung CS
    Arch Pharm Res; 2010 Sep; 33(9):1411-8. PubMed ID: 20945140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
    Tawfik MK
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
    Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
    Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressure.
    Takagi H; Mizuno Y; Goto SN; Umemoto T;
    Int J Cardiol; 2013 Sep; 167(6):3062-5. PubMed ID: 23200265
    [No Abstract]   [Full Text] [Related]  

  • 12. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
    Guthrie RM
    Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study.
    Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S;
    Hypertens Res; 2008 Apr; 31(4):657-64. PubMed ID: 18633177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.
    Kojima M; Ohashi M; Dohi Y; Kimura G
    J Hypertens; 2013 Jan; 31(1):186-91. PubMed ID: 23047595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of safety and efficacy of telmisartan-amlodipine combination in treating hypertension.
    Faruqui AA
    J Indian Med Assoc; 2008 Sep; 106(9):612-4, 624. PubMed ID: 19552093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blocker telmisartan prevents new-onset diabetes in pre-diabetes OLETF rats on a high-fat diet: evidence of anti-diabetes action.
    Zhao ZQ; Luo R; Li LY; Tian FS; Zheng XL; Xiong HL; Sun LT
    Can J Diabetes; 2013 Jun; 37(3):156-68. PubMed ID: 24070838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
    Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
    J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.
    Kadakol A; Pandey A; Goru SK; Malek V; Gaikwad AB
    Eur J Pharmacol; 2015 Oct; 765():591-7. PubMed ID: 26409041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine and telmisartan for the treatment of hypertension: the TALENT study.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1499-503. PubMed ID: 22103868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
    Hasegawa G; Fukui M; Hosoda H; Asano M; Harusato I; Tanaka M; Shiraishi E; Senmaru T; Sakabe K; Yamasaki M; Kitawaki J; Fujinami A; Ohta M; Obayashi H; Nakamura N
    Eur J Pharmacol; 2009 Mar; 605(1-3):164-9. PubMed ID: 19171132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.